Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

Clinical trial NCT07579195 · RECRUITING

Trial details

NCT number: NCT07579195
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Muscle Invasive Bladder Carcinoma Stage III Bladder Cancer AJCC v8 Stage IV Bladder Cancer AJCC v8

Start date: 2026-09-01
Primary completion: 2030-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.